Chongqing Precision Biotech Co., Ltd
Clinical trials sponsored by Chongqing Precision Biotech Co., Ltd, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New injection shows promise for tough lymphoma in early trial Results expected Dec 2026 (estimated)
- Engineered immune cells take aim at a shared marker in two blood cancers Results expected Jun 2027 (estimated)